Want to Calculate Fair Value?
Enter Stock | Calculate Fair Value

Stock: JNJ
Book Value Per Share: $32.47
EPS: $10.48
Diluted EPS TTM: $9.08
Dividend Per Share: 4.96
Dividend Yield: 3.16 %
Dividend Payout Ratio: 47%
Price To Sales Ratio TTM: 4.181
Price To Book Ratio: 4.781
PEG Ratio: 1.055
EV To EBITDA: 11.15
P/E Ratio: 17.09
Forward P/E Ratio: 14.66
Ex Dividend Date: 2025-05-27
Dividend Date: 2025-06-10
Current Price: $157.10
Previous Close: $156.66
52 Week Low: $138.38
52 Week High: $168.55
Earning Date (within 30 days): N/A
50 Day MA: $155.24
200 Day MA: $156.6
Link to Yahoo (Financial): JNJ
 
* Note: Prices are in Million (M) USD.
Description:
Johnson & Johnson (JNJ) ▼
Johnson & Johnson (J&J) is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods. Its common stock is a component of the Dow Jones Industrial Average and the company is ranked No. 36 on the 2021 Fortune 500 list of the largest United States corporations by total revenue. Johnson & Johnson is one of the world's most valuable companies, and is one of only two U.S.-based companies that has a prime credit rating of AAA, higher than that of the United States government.
These criteria used Company’s Cash, EBITDA and Debt balance to determines its fair value:
Cash : $24,105 M
Debt : $30,651 M
EBITDA : $30,025 M
Net Debt (Debt - Cash): $6,546 M

Since Net Debt is covered by EBITDA within 1 year, 3 points assigned.
This criteria used industry in which company operates:
Sector: Healthcare
Industry: Drug Manufacturers - Major

Based on industry, 3 points assigned.
This criteria used Company’s Price To Earning (P/E) Ratio to determines its fair value:
Forward PE Ratio: 14.99

Since Forward PE Ratio is less than 15, 5 points assigned.
This criteria used Company's ability to convert Sales into free cash flow to determine fair value:
Average Free Cash Flow: $15,403 M
Average Revenue: $71,370 M
Free Cash Flow to Revenue : 22 %

Since Free Cash Flow (FCF) to Revenue percentage is greater than 15, 3 points assigned.
This criteria used company's growth potential to calculate its fair value:
Latest Revenue (2024-12-31): $88,821 M
Revenue 4 Years Ago (2020-12-31): $82,584 M
Last 5 Years Average Revenue Growth: 2%

Since Revenue Growth is between 0 - 5, 1 point assigned.
This criteria used Company's ability to buy back its own share:
Latest Share Count (2024-12-31): $2,407 M
Share Count 5 Years Ago (2020-12-31): $2,671 M

Company is buying back its own shares, 3 points assigned.
This criteria used Company's dividend payout ratio to determine its fair value:
Earnings Per Share (EPS): $10.48
Dividend Per Share (DPS): $5
Payout Ratio: 47%
Dividend Yield: 3%

Since company Payout Ratio is less than 50, 2 points assigned.

Since Dividend Yield is greater than 3, 3 points assigned.
This criteria used Company's Return On Equity (ROE%) to determine its fair value:
Average ROE: 24%

Since Average ROE is greater than 20, 5 points assigned.
This criteria used Company's current price to its 52 week low price to determines its fair value:
Current Price: $157
52-Week Low: $138
Threshold Price (15% Above 52-Week Low): $159

Since Current price is within 15% threshold, 5 points assigned.
This criteria used Company's Market Cap to determines its fair value:
Market Capitalization: $373,446 M

Since Market Cap is between 100B - 500B, 3 points assigned.
% Exposure to Total Portfolio
Based on the calculated score, we recommend do not exceed 4% exposure of Total Portfolio.
Value-Trade has assigned 36 points to above Johnson & Johnson (JNJ) stock.
Twenty Years Avg PE 16, Fair Value PE 15, Industry Based PE is 14 and Growth based PE is 8. Based on these all values average assigned is 13.25.
Value-Trades has assined P/E value 13.25. Since current year earning per share is $10.48.
The fair value of Johnson & Johnson (JNJ) stock should be (13.25 x $10.48) = $138.86

Share this valuation:


Advertisement